Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
version: 4; Last updated: 2025-05-12 08:28:39+0000
Profile: Comment
Artifact Description:
This example of a Comment Profile shows a comment about another Resource (Guideline Profile) in which the commenter is not the author of the Resource commented upon.
Artifact Author: Joanne Dehnbostel:
Artifact Status: active
identifier: FEvIR Object Identifier/https://fevir.net/FOI/179694
title: Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z
citeAs:
Comment on Guideline: ADA 2021 Standards of Medical Care 8. Obesity Management for the Treatment of Type 2 Diabetes by Joanne Dehnbostel 2023-11-28T15:19:01.266Z [Database Entry: FHIR ArtifactAssessment Resource]. Contributors: Joanne Dehnbostel [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179694. Revised 2025-05-12. Available at: https://fevir.net/resources/ArtifactAssessment/179694. Computable resource at: TBD#json.
Summary | FreeToShare |
It is not clear whether the reference to Asian Americans includes native Hawaiians or Pacific Islanders. | true |